Nonetheless, in DCIS, we observed an association between higher bFGF expression with favourable prognostic criteria (low grade, positive steroid hormone receptor status, and lack of Her-2/neu expression), as described earlier for invasive breast cancer (Smith et al, 1999). This evidence concerns the gene FGF2 and ductal breast carcinoma in situ.